See also this year's filing and all EDGAR filings for this company.
PDF Report 0000707511_2013_Regenerx_Biopharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Provectus Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Expenses', 'value': 1044676, 'size_variable': 'Assets', 'size_value': 42730, 'ratio': 24.4, 'threshold': 20} |
Graph
Absolute values for 0000707511, Regenerx Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 341,497 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 9,372 |
| 3 | remainder_Assets | 5,752 |
| 4 | LiabilitiesCurrent | 704,312 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 675,598 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,022,207 |
| 9 | ResearchAndDevelopmentExpense | 1,161,967 |
| 10 | remainder_Expenses | 5,698 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,342,870 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 356,621 |
| 1 | Liabilities | 1,379,910 |
| 2 | Expenses | 2,189,872 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -1,023,289 |
| 5 | NetIncome | -847,002 |
| 6 | ComprehensiveNetIncome | -847,002 |
| 7 | BaseVar | 2,634,636 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.54 |
| 9 | EconomicCapitalRatio | 0.516 |
Edgar->Model Mapping
Feature Distribution
Change over Time
